Literature DB >> 7529448

Do prostate size and urinary flow rates predict health care-seeking behavior for urinary symptoms in men?

S J Jacobsen1, C J Girman, H A Guess, L A Panser, C G Chute, J E Oesterling, M M Lieber.   

Abstract

OBJECTIVES: To estimate the association between health care-seeking behavior for urinary dysfunction and clinical, physiologic, and anatomic measures of disease.
METHODS: A randomly selected sample (n = 475) of men aged 40 to 79 years from Olmsted County, Minnesota, was administered a previously validated questionnaire that assessed the frequency of and bother associated with urinary symptoms and health care-seeking behavior in the past year. Peak urinary flow rates were measured with a standard urometer and prostatic volume was determined by transrectal ultrasound.
RESULTS: Overall, 21 of the 475 men (4%) had seen a doctor in the past year for urinary symptoms. Men with moderate to severe symptoms (American Urological Association [AUA] Symptom Scores > 7) were 3.4 times as likely (95% confidence interval [CI] = 1.4, 8.3) to have sought medical care in the past year as men with none to mild symptoms. Men with enlarged prostates (> 40 mL) were 3.9 times as likely to have sought health care (95% CI = 1.6, 9.6), whereas men with depressed peak urine flow rates (< 10 mL/s) were only slightly more likely to have sought health care for urinary symptoms (odds ratio = 2.1, 95% CI = 0.7, 6.5). Overall, 76% of men who had sought medical care had prostatic enlargement, depressed peak urine flow rates, or moderate-severe symptoms (sensitivity). In contrast, only 55% of men who did not seek health care for urinary symptoms in the past year had mild symptoms, normal prostatic volume, and normal peak urine flow rates (specificity).
CONCLUSIONS: These data suggest that clinical, physiologic, and anatomic measures of prostatism do not adequately distinguish the men who seek medical care for their urinary symptoms from those who do not. There remain some factor(s) that apparently lead some men with minor disease to seek care and that prevent men with measurable disease from seeking care.

Entities:  

Mesh:

Year:  1995        PMID: 7529448     DOI: 10.1016/s0090-4295(95)96766-4

Source DB:  PubMed          Journal:  Urology        ISSN: 0090-4295            Impact factor:   2.649


  18 in total

1.  [Guidelines for German urologists on diagnosis of benign prostate syndrome].

Authors:  R Berges; K Dreikorn; K Höfner; U Jonas; K U Laval; S Madersbacher; M C Michel; R Muschter; M Oelke; L Pientka; C Tschuschke; U Tunn; K Schalkhäuser; B Göckel-Beining; A Heidenreich; H Rübben; K Schalkhäuser; W Thon; J Thüroff; W Weidner
Journal:  Urologe A       Date:  2003-03-12       Impact factor: 0.639

Review 2.  Short-, Intermediate-, and Long-term Quality of Life Outcomes Following Radical Prostatectomy for Clinically Localized Prostate Cancer.

Authors:  Vinay Prabhu; Ted Lee; Tyler R McClintock; Herbert Lepor
Journal:  Rev Urol       Date:  2013

3.  Underdetection of clinical benign prostatic hyperplasia in a general medical practice.

Authors:  M F Collins; R H Friedman; A Ash; R Hall; M A Moskowitz
Journal:  J Gen Intern Med       Date:  1996-09       Impact factor: 5.128

4.  [Diagnostic and differential diagnosis of benign prostate syndrome (BPS): guidelines of the German Urologists].

Authors:  R Berges; K Dreikorn; K Höfner; S Madersbacher; M C Michel; R Muschter; M Oelke; O Reich; W Rulf; C Tschuschke; U Tunn
Journal:  Urologe A       Date:  2009-11       Impact factor: 0.639

5.  Associations between variants in the cyclooxygenase 2 enzyme gene (PTGS2) and development of benign prostate enlargement.

Authors:  Jennifer L St Sauver; Michael M Lieber; Susan L Slager; Debra J Jacobson; Michaela E McGree; Steven J Jacobsen
Journal:  BJU Int       Date:  2011-04-11       Impact factor: 5.588

Review 6.  The link between benign prostatic hyperplasia and prostate cancer.

Authors:  David D Ørsted; Stig E Bojesen
Journal:  Nat Rev Urol       Date:  2012-11-20       Impact factor: 14.432

7.  The effect of benign lower urinary tract symptoms on subsequent prostate cancer testing and diagnosis.

Authors:  Christopher J Weight; Simon P Kim; Debra J Jacobson; Michaela E McGree; Stephen A Boorjian; R Houston Thompson; Bradley C Leibovich; R Jeffrey Karnes; Jennifer St Sauver
Journal:  Eur Urol       Date:  2013-01-04       Impact factor: 20.096

8.  Associations between C-reactive protein and benign prostatic hyperplasia/lower urinary tract symptom outcomes in a population-based cohort.

Authors:  Jennifer L St Sauver; Aruna V Sarma; Debra J Jacobson; Michaela E McGree; Michael M Lieber; Cynthia J Girman; Ajay Nehra; Steven J Jacobsen
Journal:  Am J Epidemiol       Date:  2009-04-24       Impact factor: 4.897

9.  Lifestyle and prostate cancer among older African-American and Caucasian men in South Carolina.

Authors:  Maureen Sanderson; Ann L Coker; Pamela Logan; Wei Zheng; Mary K Fadden
Journal:  Cancer Causes Control       Date:  2004-09       Impact factor: 2.506

10.  Men's lower urinary tract symptoms are also mental and physical sufferings for their spouses.

Authors:  Sae Chul Kim; Shin Young Lee
Journal:  J Korean Med Sci       Date:  2009-04-20       Impact factor: 2.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.